AI Article Synopsis
- - The study aimed to analyze the cost-effectiveness of polyacrylamide hydrogel urethral bulking compared to other treatments for stress urinary incontinence (SUI).
- - Among the treatments evaluated, midurethral sling (MUS) showed the highest effectiveness followed closely by polyacrylamide hydrogel, with minimal differences in quality-adjusted life-years (QALYs).
- - Polyacrylamide hydrogel becomes more cost-effective if over 58% of the procedures are done in-office, making it a reasonable option depending on patient preferences, even though MUS is the preferred treatment due to its higher effectiveness.
Article Abstract
Our objective was to perform a cost-effectiveness analysis comparing polyacrylamide hydrogel urethral bulking with other surgical and nonsurgical treatments for stress urinary incontinence (SUI). We created a cost-effectiveness analysis using TreeAge Pro, modeling eight SUI treatments. Treatment with midurethral sling (MUS) had the highest effectiveness (1.86 quality-adjusted life-years [QALYs]), followed by polyacrylamide hydrogel (1.82 QALYs), with a difference (Δ 0.02/year) less than the minimally important difference for utilities of 0.03 annually. When the proportion of polyacrylamide hydrogel urethral bulking procedures performed in the office setting is greater than 58%, polyacrylamide hydrogel is a cost-effective treatment for SUI, along with pessary, pelvic floor physical therapy, and MUS. Although MUS is more effective and, therefore, the preferred SUI treatment, polyacrylamide hydrogel is a reasonable alternative depending on patient preferences and treatment goals.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/AOG.0000000000005503 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!